By Marie Rosenthal
The CDC’s Advisory Committee on Immunization Practices (ACIP) voted to include the new recombinant, adjuvanted zoster vaccine (Shingrix, GlaxoSmithKline) in the adult vaccination recommendations for the prevention of shingles (herpes zoster).